Tag: LivaNova

All

12-Month Results from LivaNova’s OSPREY Clinical Study Published

Full data set demonstrates proximal hypoglossal nerve stimulation yields clinically significant and sustained improvements for patients with moderate to severe OSA.

FDA Approves LivaNova’s aura6000 Neurostimulator for OSA
How the Pivotal Trial for LivaNova’s OSA Neurostimulator Is Different from the Rest
New Trial Reveals Sustained Benefits for Investigational Sleep Apnea Neurostimulator
Investigational Neurostimulator for OSA Cuts AHI By 66%
Neurostimulator Offers Relief to Young Man with Down Syndrome and OSA
LivaNova Adds Chief Innovation Officer

All

LivaNova Concludes Enrollment in OSPREY Trial for Sleep Apnea Neurostimulator

The trial will evaluate the aura6000 System for the reduction of AHI in adults with moderate to severe obstructive sleep apnea who have failed or are unwilling to use CPAP.